Coenzyme Q10 does not soften or unclog blood vessels. The pharmacological effects of this product include increasing the oxygen utilization efficiency of ischemic myocardium and improving cardiac decompensation. The pharmacological classification of Coenzyme Q10 is other non-therapeutic adjuvant products, which are mainly used for adjuvant treatment of cardiovascular diseases (chronic cardiac insufficiency, viral myocarditis, etc.), hepatitis (chronic active hepatitis, subacute hepatic necrosis, viral hepatitis, etc.), and the comprehensive treatment of cancer (to alleviate some of the adverse effects caused by radiotherapy and other therapeutic treatments). The pharmacological effects of coenzyme Q10 include improving the oxygen utilization efficiency of ischemic myocardium, activating myocardium to produce ATP, improving cardiac hypoplasia, and antialdosterone effects. The mechanism of action is that coenzyme Q10 is taken up by the mitochondria of cardiomyocytes and acts on ischemic myocardium to improve the energy metabolism of myocardium during hypoxia and thus improve the efficiency of oxygen utilization, which can’t soften and unclog the blood vessels. It is recommended that patients who are not feeling well go to a regular hospital in time, and follow the doctor’s instructions for symptomatic treatment.